Optic Capture Without Anterior Vitrectomy in Pediatric Cataract Surgery

Sponsor
Ege University (Other)
Overall Status
Completed
CT.gov ID
NCT05461040
Collaborator
(none)
37
1
2
36
1

Study Details

Study Description

Brief Summary

Purpose: To compare two pediatric cataract surgery procedures: intraocular lens (IOL) optic capture without anterior vitrectomy (AV) and in-the-bag IOL implantation with AV.

Setting: Ege University Medical School Hospital, Izmir, Turkey. Design: Prospective randomized control clinical trial. Methods: Patients were randomly assigned to two groups: optic capture without AV (Group 1) or in-the-bag implantation with AV (Group 2). The following variables were compared: visual acuity, intraocular pressure, refractive errors, IOL tilt and decentration, lenticular astigmatism, anterior-posterior synechia, inflammatory cell deposits on IOL and post-operative complications.

Condition or Disease Intervention/Treatment Phase
  • Procedure: optic capture
  • Procedure: In-the-bag implantation of Intraocular lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
37 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Optic Capture Without Anterior Vitrectomy in Pediatric Cataract Surgery
Actual Study Start Date :
Apr 30, 2018
Actual Primary Completion Date :
Apr 30, 2021
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Optic capture of Intraocular lens without anterior vitrectomy (Group 1)

Procedure: optic capture
optic capture of Intraocular lens without anterior vitrectomy

Experimental: in-the-bag implantation of Intraocular lens with anterior vitrectomy (Group 2).

Procedure: In-the-bag implantation of Intraocular lens
in-the-bag implantation of Intraocular lens with anterior vitrectomy

Outcome Measures

Primary Outcome Measures

  1. The prevalence of visual axis opacification [through study completion, an average of 2 years]

    Eyes were evaluated for presence of visual axis opacification at the slit lamp examinations.

  2. The prevalence of inflammatory deposits on Intraocular lens surface [through study completion, an average of 2 years]

    Eyes were evaluated presence of inflammatory deposits between the margins of capsulorhexis at the slit lamp examinations.

  3. The prevalence of anterior-posterior synechia [through study completion, an average of 2 years]

    Eyes were evaluated for presence of anterior-posterior synechia at the slit lamp examinations.

  4. Measurements of Intraocular lens tilt and decentration. [at the postoperative one-year]

    Measurement of Intraocular lens (IOL) position at vertical and horizontal meridians at the Scheimpflug images captured with corneal topography. Scheimpflug images were obtained (Pentacam HR, Oculus Optikgerate Gmbh, Wetzlar, Germany) at one postoperative year. The horizontal and vertical meridians' photographs were analyzed.These images were processed in AutoCAD LT 2020 2D CAD software for IOL position assessment.(1) IOL Center: Two arches were drawn that fit perfectly on the anterior and posterior surfaces of the IOL. The points where these two arcs met were marked. Between these intersection points, a line was drawn. The midpoint of this line was accepted as the IOL center. (2) IOL Decentration: It was determined by measuring the distance (mm) from the IOL center point to the pupillary axis. (3) IOL Tilt: Angle (degree) between the IOL axis and the line passing through the iridocorneal angle.

  5. Prediction error [at the post-operative one-month]

    Refraction prediction error (PE) was found by subtracting the early post-operative refraction from the pre-operative target refraction.

Secondary Outcome Measures

  1. Intraocular pressure [at the postoperative one year]

    Intraocular pressure was measured by Tonopen (Reichart Technologies, Depew, NY), Perkins handheld Mk2 tonometry (Haag-Streit, Koeniz, Switzerland) or Goldmann applanation tonometry (Haag Streit, Koeniz, Switzerland), considering the patient's age and compliance.

  2. Lenticular astigmatism [One-year postoperatively]

    Calculated by subtracting corneal astigmatism from manifest astigmatism.

  3. Posterior segment complications [through study completion, an average of 2 years]

    In the fundoscopic examination, the patients were evaluated for possible posterior segment complications such as retinal detachment, cystoid macular edema, and intraocular hemorrhage.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children with congenital or developmental cataracts who had cataract surgery and primary IOL implantation at a tertiary care referral institute were included.
Exclusion Criteria:
  • Traumatic or uveitic cataract, corneal opacity, iris coloboma, microphthalmia, microcornea, persistent fetal vascularization, congenital glaucoma, and retinopathy of prematurity were all considered exclusion criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ege University Izmir Turkey

Sponsors and Collaborators

  • Ege University

Investigators

  • Principal Investigator: Ali Devebacak, M.D., Ege University, Department of Ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ali Devebacak, Principal Investigator, Consultant Ophthalmologist, Ege University
ClinicalTrials.gov Identifier:
NCT05461040
Other Study ID Numbers:
  • OC3506
First Posted:
Jul 15, 2022
Last Update Posted:
Jul 15, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ali Devebacak, Principal Investigator, Consultant Ophthalmologist, Ege University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2022